This inventor holds 1 USPTO granted patent. Top assignee: University of South Alabama. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Michael V Cohen: Innovator in Cardioprotective Therapies
Introduction
Michael V Cohen is a notable inventor based in Mobile, AL (US). He has made significant contributions to the field of cardiology through his innovative research and patenting efforts. His work focuses on improving treatments for myocardial infarction, which is a critical area in medical science.
Latest Patents
Cohen holds a patent titled "Combined administration of cysteine-aspartic protease inhibitors with P2Y12 receptor antagonists protects the heart against myocardial infarction." This patent outlines methods for treating myocardial infarction by administering a platelet anti-aggregate, a cysteine-aspartic protease inhibitor, and reperfusion therapy. The patent emphasizes the use of specific P2Y receptor antagonists and cysteine-aspartic protease inhibitors, providing an improved cardioprotective effect compared to current standard care.
Career Highlights
Michael V Cohen is affiliated with the University of South Alabama, where he continues to advance his research in cardiology. His work has garnered attention for its potential to enhance patient outcomes in heart-related conditions. With 1 patent to his name, Cohen exemplifies the spirit of innovation in medical research.
Collaborations
Cohen has collaborated with notable colleagues such as Jonathon P Audia and James M Downey. These partnerships have contributed to the development of his groundbreaking research and patent.
Conclusion
Michael V Cohen's contributions to cardiology through his innovative patent demonstrate his commitment to improving heart health. His work is a testament to the importance of research and innovation in the medical field.